Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan fumarate + amoxicillin dual therapy vs bismuth-based quadruple therapy for Helicobacter pylori infection
ChiCTR2100055101Phase 4Recruiting
- Sponsor
- Changzhou Second People's Hospital
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vonoprazan and amoxicillin in Helicobacter pylori infection (2 arms), sponsored by Changzhou Second People's Hospital. Primary endpoint: Helicobacter pylori eradication rate. Started Sep 2021; status: recruiting.
02
Drugs
vonoprazanamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2100055101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100055101.